| Pharmaceutical active ingredients: |
| Rivastigmine Hydrogen Tartrate |
| Available forms, composition and doses of Exelon: |
| Capsules; Oral; Rivastigmine Hydrogen Tartrate 0.5 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 1 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 1.5 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 3 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 4.5 mgCapsules; Oral; Rivastigmine Hydrogen Tartrate 6 mgFilm, Extended Release; Transdermal; Rivastigmine 4.6 mg / 24 hrFilm, Extended Release; Transdermal; Rivastigmine 9.5 mg / 24 hrSolution; Oral; Rivastigmine Hydrogen Tartrate 2 mg / ml |
| Exelon medical category: |
| Human:Neurodegenerative disease drugsParasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06DA03 - Rivastigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisFour StarZuellig Pharma |
| Related documents and information about Exelon: |
| Exelon prescribing information (PDF)Exelon Patch prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Exel | Meloxicam | Senosiain Laboratorios |
| Exelderm | Sulconazole Nitrate | Bristol-Myers Squibb; Derma UK; Ranbaxy; Schwarz Pharma; Syntex; Westwood-Squibb |
| Exel-G | Clobetasol Propionate; Gentamicin Sulfate | Ranbaxy |
| Exel-M | Clobetasol Propionate; Miconazole Nitrate | Ranbaxy |
| Exelmin | Cambendazole; Mebendazole | UCI-Farma Industria Farmaceutica |
| Exelon Parche | Rivastigmine Hydrogen Tartrate | Novartis; Zuellig Pharma |
| Exelon Patch | Rivastigmine Hydrogen Tartrate | Novartis; Four Star; Zuellig Pharma |
| Exelyte | Sodium Phosphate Dibasic Dihydrate; Sodium Phosphate Monobasic Dihydrate | USV, India |
| Exemestance | Exemestane | Unidentified Pharmaceutical Company |
| Exemestane | Exemestane | Roxane Laboratories |